Analysts' Actions -- Kimberly-Clark, IberiaBank, Ionis Pharma, Actuant and More

RATINGS CHANGES

Abbott Laboratories (ABT) was upgraded to buy at TheStreet Ratings. You can view the full analysis from the report here: ABT.

Actuant (ATU) was upgraded to overweight from sector weight at Keybanc. $32 price target. The new CEO is making positive changes and the industrial business appears to be rebounding, Keybanc said. 

IberiaBank (IBKC) was upgraded to outperform from market perform at JMP Securities. $94 price target. Sabadell acquisition will add to earnings, JMP said. 

Ionis Pharma (IONS) was downgraded to sell from neutral at Goldman Sachs. $25 price target. There are questions on the market viability of two products in Phase 3 trials, Goldman said. 

Kimberly-Clark (KMB) was downgraded to hold from buy at Societe Generale. $144 price target. The company is facing increased price competition, Societe said. 

Luminex (LMNX) was downgraded to hold at TheStreet Ratings. You can view the full analysis from the report here: LMNX.

Loxo Oncology (LOXO) was downgraded to neutral at Citigroup. The valuation is less attractive, based on a $45 price target, Citi said. 

Mednax (MD) was downgraded to neutral from overweight at JPMorgan. The valuation is more attractive, based on a $69 price target, JPMorgan said. 

This article was written by a staff member of TheStreet.

More from Stocks

Netflix, Amazon, Jerome Powell, Walmart and Microsoft - 5 Things You Must Know

Netflix, Amazon, Jerome Powell, Walmart and Microsoft - 5 Things You Must Know

Did Netflix Earnings Just Stomp Out Any Chance of a Big Market Rally?

Did Netflix Earnings Just Stomp Out Any Chance of a Big Market Rally?

3 Stocks Poised to Move the Markets This Week: Goldman Sachs, Microsoft, GE

3 Stocks Poised to Move the Markets This Week: Goldman Sachs, Microsoft, GE

Why Netflix Stock Is Still a Buy: Shark Tank Star Kevin O'Leary

Why Netflix Stock Is Still a Buy: Shark Tank Star Kevin O'Leary

Here's How Shark Tank Star Kevin O'Leary Decides What Stocks to Invest In

Here's How Shark Tank Star Kevin O'Leary Decides What Stocks to Invest In